StrideBio

About:

StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.

Website: http://www.stridebio.com/

Top Investors: Novo Holdings, Alexandria Venture Investments, Northpond Ventures, Takeda Ventures, Sarepta Therapeutics

Description:

StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes to overcome current limitations of first-generation gene therapies. The company was founded in 2015 and is headquartered in Durham, North Carolina.